TUDOR INVESTMENT CORP ET AL - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$16,000
-86.9%
12,893
-64.1%
0.00%
-100.0%
Q2 2020$122,000
-14.1%
35,957
+64.2%
0.01%
+50.0%
Q1 2017$142,000
-62.9%
21,900
-74.6%
0.00%
-60.0%
Q4 2016$383,000
+3.2%
86,378
+8.7%
0.01%
+11.1%
Q3 2016$371,000
+32.0%
79,444
+85.8%
0.01%
+50.0%
Q2 2016$281,000
+269.7%
42,767
+257.1%
0.01%
+200.0%
Q1 2016$76,000
-68.3%
11,976
-69.9%
0.00%
-71.4%
Q4 2015$240,000
+31.9%
39,787
+30.6%
0.01%
+16.7%
Q3 2015$182,000
-21.2%
30,458
-19.8%
0.01%
-14.3%
Q1 2015$231,000
+100.9%
38,000
+192.3%
0.01%
+16.7%
Q4 2013$115,00013,0000.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders